Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 7/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | XBP1 | P17861 | 1/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.51 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ULK1 | O75385 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | BTK | Q06187 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25144046 | 0.93 | PTGS1 (0.61) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL25143903 | 0.92 | PTGS1 (0.62) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL29751959 | 0.89 | PTGS1 (0.60) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL24605877 | 0.89 | PTGS1 (0.60) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL25141363 | 0.88 | PTGS1 (0.62) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL16367720 | 0.88 | PTGS1 (0.66) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL25143905 | 0.88 | PTGS1 (0.66) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL25141316 | 0.87 | PTGS1 (0.65) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL15445156 | 0.86 | PTGS1 (0.56) | PTGS1MAPTMEN1LMNAKMT2A | |
| SCHEMBL23802516 | 0.85 | KCNK3 (0.60) | PTGS1MAPTMEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230119106-A1 | Diamine Compound, Polyimide Precursor and Polyimide Prepared by Using the Same, Composition for Forming Polyimide Film and Polyimide Film Prepared by Using the Same, and Uses Thereof | SK INNOVATION CO., LTD. (KR) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119106-A1 | Diamine Compound, Polyimide Precursor and Polyimide Prepared by Using the Same, Composition for Forming Polyimide Film and Polyimide Film Prepared by Using the Same, and Uses Thereof | PUF60, WASF2, THEM6 | PTGS1 3254/4885MAPT 748/4885MEN1 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.